Manufacturing

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Thomas LaVake, manager, worldwide environment, health & safety at Johnson & Johnson, provides a perspective on sustainability practices for the pharmaceutical industry.

Building Sustainability into the Supply Chain and Pharmaceutical Operations

Jeff Robertson is Director and General Manager at ARmark Authentication Technologies, LLC (PA, USA).

Jeff Robertson talks about a unique form of micro-tag technology that can be applied to solid dose pharmaceuticals.

A new tool to battle counterfeits

Julian Mosquera, Director of LCP Consulting, advises how pharma companies can make their supply chains leaner.

How to manage the threat of the global supply chain and save money

Thomas LaVake, manager, worldwide environment, health &safety at Johnson & Johnson, provides a perspective of sustainability practices for the pharmaceutical industry.

The Evolving Global Pharmaceutical Supply Chain

Collaborative planning and execution among clinical research, clinical operations, and supply-chain managers are key elements in effectively managing an increasingly complex and global supply chain for clinical trial materials.

Managing the Clinical-Trial-Materials Supply Chain

Angie Drakulich was editorial director of Pharmaceutical Technology.

The US Food and Drug Administration issued a draft guidance for industry, Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting, on July 13.

Physical Chemical Identifiers Play a Role in New FDA Anticounterfeiting Draft Guidance

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation on measures to strengthen the country's drug supply chain.

UK Strengthens Drug Supply Chain

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

During the past decade, big pharmaceutical companies have been making major efforts to restructure their manufacturing networks. In their haste to shed costs and assets, however, some may be adding risk to their product supply chains.

Penny-wise, pound-foolish

Consumer-care products, electronics, and select industrial firms comprise AMR Research's Supply Chain Top 25 for 2009, offering an opportunity for the pharmaceutical industry to examine best practices in supply-chain management.

Best Practices in the Supply Chain

As regulators work to curb counterfeiting, industry finds benefits to gaining granular data about the supply chain. This article contains bonus online-exclusive material.